| Newest Omicron subvariants can evade boosters, antibody therapies |
| Wednesday, July 06, 2022 05:03 PM |
| The latest Omicron subvariants behind new COVID-19 surges in the United States and abroad have an enhanced ability to escape immunity conferred by three vaccine doses and all but one antibody therapy tested, finds a laboratory study published yesterday in Nature. Read more. |
Daily News
- 5 Things to Know about Infant Immunization
- Vaccination Is the Best Protection Against Measles
- Marijuana and Youth: The Impact of Marijuana Use on Teen Health and Wellbeing
- Mother of Chicago child with measles: It was ‘one of the scarier moments of my life’
- Study points to lack of formal education on cannabis in dentistry
Our Sponsors
